Leslie Katz
Ophthalmology · Philadelphia, PANPI 1306887542
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $83,175 of the $104,849 with a category attached, or 79.3%. AbbVie accounts for 70.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $73,035 and has fallen 99.5% since, to $332 in 2023. Among ophthalmology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $639.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$74K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$29K
- Glaukos Corporation$2K
- Carl Zeiss Meditec, Inc.$345
- Quidel Corporation$157
- Dompe US, Inc.$56
Across 12 payments — averaging $4524.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$28K
- Carl Zeiss Meditec, Inc.$27K
What the payments were for
- Consulting fees$1,7202%
- Speaking & faculty fees$83,17579%
- Travel & lodging$16,24315%
- Food & beverage$3,7124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 119 | $73,591 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 29 | $28,930 |
| Glaukos Corporation | 8 | $1,771 |
| Carl Zeiss Meditec, Inc. | 2 | $345 |
| Quidel Corporation | 5 | $157 |
| Dompe US, Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUMIGAN$64,708
- COMBIGAN$46,329
- VYZULTA$28,420
- ALPHAGAN P$6,000
- iStent inject Trabecular Micro-Bypass Stent System$1,495
- iStent Trabecular Micro-Bypass Stent System$1,224
- ISTALOL$500
How this compares
$104,849 in reported general payments places this provider in the 95th percentile of 920 ophthalmology providers in Pennsylvania.
Other ophthalmology in Philadelphia
- Julia HallerPhiladelphia$1.5M
- Beeran MeghparaPhiladelphia$496K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
- Anton KolomeyerPhiladelphia$355K
- Durga BorkarPhiladelphia$150K
- Rachel NiknamPhiladelphia$142K
- Joseph MarkoffPhiladelphia$130K
- Zeba SyedPhiladelphia$99K
- Cesar BricenoPhiladelphia$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.